Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MF 934

Known as: MF-934 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The antibacterial activity of the new fluoroquinolone rufloxacin (MF 934) was evaluated against 1095 clinical isolates and… Expand
  • table 1
  • table I
  • table I
1993
1993
The antimicrobial activity of the new fluoroquinolone rufloxacin (MF 934) was evaluated by a standardized agar dilution method… Expand
1992
1992
Ocular pharmacokinetics of rufloxacin (MF 934), a new monofluorinated quinolone derivative, has been investigated in rabbits. A… Expand
1989
1989
Rufloxacin (MF-934) is a new quinolone which shows in vitro antibacterial activity against E. coli, Salmonella, Klebsiella… Expand
1989
1989
  • A. Farina
  • Journal of pharmaceutical and biomedical analysis
  • 1989
  • Corpus ID: 43449557
A simple and rapid fluorimetric method for the determination of 9-fluoro-10-[N-(4'-methyl)piperazinyl]-7-oxo-2,3-dihydro-7H… Expand
1988
1988
The kinetics of a new fluoroquinolone, rufloxacin (MF-934), have been studied in rats, dogs and monkeys. The drug is… Expand
Highly Cited
1987
Highly Cited
1987
A series of pyridobenzothiazine acid derivatives was synthesized and their in vitro antibacterial activity was evaluated. The 1,4… Expand
1987